80 related articles for article (PubMed ID: 25928025)
1. Decreasing utilization of surgical interventions amongst patients with pancreatic neuroendocrine tumor with liver metastases.
Amini N; Demyan L; Shah M; Standring O; Gazzara E; Lad N; Deperalta DK; Weiss M; Deutsch G
Am J Surg; 2024 Jan; 227():77-84. PubMed ID: 37798150
[TBL] [Abstract][Full Text] [Related]
2. Accuracy and Prognostic Impact of Nodal Status on Preoperative Imaging for Management of Pancreatic Neuroendocrine Tumors: A Multi-Institutional Study.
Zhang N; He J; Maithel SK; Poultsides G; Rocha F; Weber S; Fields R; Idrees K; Cho C; Lv Y; Zhang XF; Pawlik TM
Ann Surg Oncol; 2024 May; 31(5):2882-2891. PubMed ID: 38097878
[TBL] [Abstract][Full Text] [Related]
3. Impact of Surgery on Non-Functional Pancreatic Neuroendocrine Tumors ≤2 cm: Analyses With Propensity Score-Based Inverse Probability of Treatment Weighting.
Ye J; Wu H; Li J; Liu C
Front Surg; 2022; 9():890564. PubMed ID: 36071950
[TBL] [Abstract][Full Text] [Related]
4. Risk factors for lymph node metastasis in patients with pancreatic neuroendocrine neoplasms.
Nakao Y; Hayashi H; Yamashita YI; Takashi O; Matsumura K; Uemura N; Kitamura F; Itoyama R; Yusa T; Taki K; Miyata T; Higashi T; Nakagawa S; Okabe H; Imai K; Baba H
World J Clin Oncol; 2022 Jun; 13(6):520-528. PubMed ID: 35949434
[TBL] [Abstract][Full Text] [Related]
5. Value of lymphadenectomy in patients with surgically resected pancreatic neuroendocrine tumors.
Zhang Z; Wang F; Li Z; Ye Z; Zhuo Q; Xu W; Liu W; Liu M; Fan G; Qin Y; Zhang Y; Chen X; Yu X; Xu X; Ji S
BMC Surg; 2022 May; 22(1):160. PubMed ID: 35538535
[TBL] [Abstract][Full Text] [Related]
6. High vimentin expression with E-cadherin expression loss predicts a poor prognosis after resection of grade 1 and 2 pancreatic neuroendocrine tumors.
Zhou B; Xiang J; Jin M; Zheng X; Li G; Yan S
BMC Cancer; 2021 Mar; 21(1):334. PubMed ID: 33789624
[TBL] [Abstract][Full Text] [Related]
7. Systematic Review and Metaanalysis of Lymph Node Metastases of Resected Pancreatic Neuroendocrine Tumors.
Tanaka M; Heckler M; Mihaljevic AL; Probst P; Klaiber U; Heger U; Schimmack S; Büchler MW; Hackert T
Ann Surg Oncol; 2021 Mar; 28(3):1614-1624. PubMed ID: 32720049
[TBL] [Abstract][Full Text] [Related]
8. The North American Neuroendocrine Tumor Society Consensus Paper on the Surgical Management of Pancreatic Neuroendocrine Tumors.
Howe JR; Merchant NB; Conrad C; Keutgen XM; Hallet J; Drebin JA; Minter RM; Lairmore TC; Tseng JF; Zeh HJ; Libutti SK; Singh G; Lee JE; Hope TA; Kim MK; Menda Y; Halfdanarson TR; Chan JA; Pommier RF
Pancreas; 2020 Jan; 49(1):1-33. PubMed ID: 31856076
[TBL] [Abstract][Full Text] [Related]
9. FGD4 (Frabin) Overexpression in Pancreatic Neuroendocrine Neoplasms.
Shahid M; George TB; Saller J; Haija M; Sayegh Z; Boulware D; Strosberg J; Chakrabarti R; Coppola D
Pancreas; 2019; 48(10):1307-1311. PubMed ID: 31688594
[TBL] [Abstract][Full Text] [Related]
10. Preoperative neutrophil-to-lymphocyte ratio and tumor-related factors to predict lymph node metastasis in nonfunctioning pancreatic neuroendocrine tumors.
Zhou B; Deng J; Chen L; Zheng S
Sci Rep; 2017 Dec; 7(1):17506. PubMed ID: 29235538
[TBL] [Abstract][Full Text] [Related]
11. Pancreatic neuroendocrine tumors: the basics, the gray zone, and the target.
Kelgiorgi D; Dervenis C
F1000Res; 2017; 6():663. PubMed ID: 28529726
[TBL] [Abstract][Full Text] [Related]
12. Significance of lymph node metastasis in pancreatic neuroendocrine tumor.
Taki K; Hashimoto D; Nakagawa S; Ozaki N; Tomiyasu S; Ohmuraya M; Arima K; Kaida T; Higashi T; Sakamoto K; Sakata K; Okabe H; Nitta H; Hayashi H; Chikamoto A; Beppu T; Takamori H; Hirota M; Baba H
Surg Today; 2017 Sep; 47(9):1104-1110. PubMed ID: 28229300
[TBL] [Abstract][Full Text] [Related]
13. Patient-Reported Outcomes and Quality of Life with Sunitinib Versus Placebo for Pancreatic Neuroendocrine Tumors: Results From an International Phase III Trial.
Vinik A; Bottomley A; Korytowsky B; Bang YJ; Raoul JL; Valle JW; Metrakos P; Hörsch D; Mundayat R; Reisman A; Wang Z; Chao RC; Raymond E
Target Oncol; 2016 Dec; 11(6):815-824. PubMed ID: 27924459
[TBL] [Abstract][Full Text] [Related]
14. Prognostic Value of Lymph Node Status and Extent of Lymphadenectomy in Pancreatic Neuroendocrine Tumors Confined To and Extending Beyond the Pancreas.
Conrad C; Kutlu OC; Dasari A; Chan JA; Vauthey JN; Adams DB; Kim M; Fleming JB; Katz MH; Lee JE
J Gastrointest Surg; 2016 Dec; 20(12):1966-1974. PubMed ID: 27714644
[TBL] [Abstract][Full Text] [Related]
15. Neuroendocrine Tumors of the Large Intestine: Clinicopathological Features and Predictive Factors of Lymph Node Metastasis.
Kojima M; Ikeda K; Saito N; Sakuyama N; Koushi K; Kawano S; Watanabe T; Sugihara K; Ito M; Ochiai A
Front Oncol; 2016; 6():173. PubMed ID: 27486567
[TBL] [Abstract][Full Text] [Related]
16. Neuroendocrine tumors of the pancreas: a retrospective single-center analysis using the ENETS TNM-classification and immunohistochemical markers for risk stratification.
Brunner SM; Weber F; Werner JM; Agha A; Farkas SA; Schlitt HJ; Hornung M
BMC Surg; 2015 Apr; 15():49. PubMed ID: 25928025
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the World Health Organization 2010 grading system in surgical outcome and prognosis of pancreatic neuroendocrine tumors.
Yang M; Tian BL; Zhang Y; Su AP; Yue PJ; Xu S; Wang L
Pancreas; 2014 Oct; 43(7):1003-8. PubMed ID: 24945681
[TBL] [Abstract][Full Text] [Related]
18. Predictors of lymph node metastases and impact on survival in resected pancreatic neuroendocrine tumors: a single-center experience.
Wong J; Fulp WJ; Strosberg JR; Kvols LK; Centeno BA; Hodul PJ
Am J Surg; 2014 Nov; 208(5):775-780. PubMed ID: 24997491
[TBL] [Abstract][Full Text] [Related]
19. Surgical experience with nonfunctioning neuroendocrine tumors of the pancreas.
Matthews BD; Heniford BT; Reardon PR; Brunicardi FC; Greene FL
Am Surg; 2000 Dec; 66(12):1116-22; discussion 1122-3. PubMed ID: 11149582
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
